Aromasin (exemestane)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  July 2016 WARNINGS AND PRECAUTIONS 2 subsections added: Use in Premenopausal Women AROMASIN is not indicated for the...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts